<qa>  What is the name of the patient who consents to participate?There is no predetermined number of patients that must be enrolled into the outcome survey. Patients who have been diagnosed biochemically or genetically with Fabry disease that consent to participate will be followed for an undetermined amount of time i.e., until the sponsor closes the outcome survey or the patient withdraws consent. 